HAEMOCTIN SDH 250 FOR INJECTION 250 iu/vial
Product details
Registration number: SIN10411P
Classification: Prescription Only
Active ingredients: HUMAN BLOOD COAGULATION FACTOR VIII
Strength: 250 iu/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: GRIFOLS ASIA PACIFIC PTE. LTD.
ATC code: B02BD02
HSA approval date: 11 November 1998
Manufacturer(s):
- BIOTEST AG
- Laboratorios Grifols, S.A. (Solvent)
- Biotest AG (Solvent)
- B.Braun Medical S.A. (Solvent)
Manufacturing country/countries: SPAIN; GERMANY
What are the HSA registration number and classification for HAEMOCTIN SDH 250 FOR INJECTION 250 iu/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN10411P
Classification: Prescription Only
What active ingredients and strength are recorded for HAEMOCTIN SDH 250 FOR INJECTION 250 iu/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: HUMAN BLOOD COAGULATION FACTOR VIII
Strength: 250 iu/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for HAEMOCTIN SDH 250 FOR INJECTION 250 iu/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for HAEMOCTIN SDH 250 FOR INJECTION 250 iu/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: GRIFOLS ASIA PACIFIC PTE. LTD.
Which manufacturers and countries are listed for HAEMOCTIN SDH 250 FOR INJECTION 250 iu/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- BIOTEST AG
- Laboratorios Grifols, S.A. (Solvent)
- Biotest AG (Solvent)
- B.Braun Medical S.A. (Solvent)
Manufacturing country/countries: SPAIN; GERMANY
Where can I look up HAEMOCTIN SDH 250 FOR INJECTION 250 iu/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN10411P or the exact product name HAEMOCTIN SDH 250 FOR INJECTION 250 iu/vial. The general register link does not preselect this product.
What are the source dates for this HAEMOCTIN SDH 250 FOR INJECTION 250 iu/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this HAEMOCTIN SDH 250 FOR INJECTION 250 iu/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN10411P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)